Reprogramming tumour cells using an antimalarial drug
17 February 2021
Results from the ATOM clinical trial at the University of Oxford have shown that the anti-malarial drug Atovaquone can reduce very low oxygen tumour environments. This has the potential to make cancers behave less aggressively and to improve the impact of everyday cancer treatments.
Hidden lung damage from COVID-19 revealed in new study
2 December 2020
Research Translational Research
Early findings from a study into longer-term damage amongst patients recovering from COVID-19 suggest that the use of cutting-edge scanning techniques may detect previously unseen lung damage.
Professor Sibson secures further MRC DPFS funding
20 October 2020
Awards & Appointments Clinical Trials Translational Research
Prof. Sibson together with her co-applicants Prof. Anthony, Dr Campbell and Prof. Middleton have now been awarded a second MRC DPFS grant, for £3.3 million, to acquire further preclinical data to support the case for clinical translation, to develop the mutTNF production for human use and to undertake pre-clinical toxicology.
Oxfordshire-based SCAN pathway wins BMJ award
9 October 2020
A pathway designed to investigate individuals with non-specific but concerning symptoms of cancer wins the BMJ Awards 2020 Cancer Care Team of the Year.
Tackling the serious side effects of cancer treatment in an ageing population
20 August 2020
Prof. Anne Kiltie and her team discuss their important work into the effects of radiosensitisation on ageing cancer patients with the CRUK Science Blog.
Vice-Chancellor's Innovation Awards 2020
27 July 2020
Awards & Appointments Department
Congratulations to Professor Anna Schuh and her team who are the Winners of the Teamwork category in the Vice-Chancellor Innovation Awards 2020 for their work on SEREN_A Social Enterprise to deliver DNA-based diagnostics that improves outcomes of children and young adults with blood diseases in sub-Saharan Africa.
New digital classification method using AI developed for colorectal cancer
22 July 2020
Artificial Intelligence Research Translational Research
Understanding the molecular subtype of a cancer is becoming an importance part of the diagnostic process as it helps a doctor better understand a patient’s prognosis, determine the best course of action for treatment and helps researchers devise new, more-efficient, precision therapies.
The CNIO creates a collaborative platform to streamline brain metastasis research
8 July 2020
Professor Nicola Sibson has been involved in the CNIO platform to compile a repository for brain metastasis cell lines.
Oxford University to lead a new national programme of AI research to improve lung cancer screening
3 July 2020
Artificial Intelligence Funding
UK Research and Innovation, Cancer Research UK and industry are investing more than £11 million in an Oxford-led artificial intelligence (AI) research programme to improve the diagnosis of lung cancer and other thoracic diseases.
Vice-Chancellor's Education Awards 2020
1 July 2020
Awards & Appointments Department Teaching
We are delighted to announce that three members of the Department of Oncology have been part of a project team which has been awarded a Vice-Chancellor's Education Award for 2020.
Virtual teaching with AimHi
4 June 2020
One of our scientists, Dr Hannah Bolland, has become a virtual teacher, connecting school students with science.
New Fellow of the Society for Radiological Protection
23 April 2020
Awards & Appointments Research
Many congratulations to Dr Mark Hill, who has become a Fellow of the Society for Radiological Protection (FSRP).
Integrating Cancer Imaging Biomarker Clinical Research Across the UK
26 March 2020
UK National Cancer Imaging Translational Accelerator (NCITA) establishes infrastructure for validation and adoption of cancer imaging biomarkers as decision-making tools in clinical trials and NHS practice. Researchers and medical experts from nine world-leading medical imaging centres across the UK come together to form an integrated infrastructure for standardising and validating cancer imaging biomarkers for clinical use.
Ramandan Group publish original scientific article in Nature Communications
9 March 2020
Group of Professor Kristijan Ramadan has published an original scientific article in Nature Communications today. The article has the first report of a new autophagy receptor TEX264, which may be involved in tumours developing drug resistance.
Lifetime Achievement Award for Prof Talbot
27 February 2020
Awards & Appointments Department
Congratulations to Professor Denis Talbot who has been awarded the Lifetime Achievement Award from the British Thoracic Oncology Group (BTOG).
Careers Fair
26 February 2020
On 13 February, OCTO Trial Manager Lucy Griffiths staffed a stand about Clinical Trials at a tri-school Careers Fair in West London.
Science and Safety
21 February 2020
On 3 February, we hosted a visiting group of students from Buckinghamshire College.
Teaching in the Oxford Department of Education
17 February 2020
Friday 14 February was the day of our annual visit to Oxford's Department of Education to spend some time with their trainee teachers.